Contingency Management to Improve Medication for Opioid Use Disorder Continuation After the Emergency Department
Key facts
- Who runs it
- University of Vermont
- Where
- Burlington, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 12 people enrolled
- Started
- 2 Sept 2025
- Ended
- 16 Oct 2026
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Contingency Management
- Usual care as prescribed by the ED physicians
- Record updated
- 20 October 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 7 criteriaShow less
Who cannot take part
- Pending incarceration in the next 30 days
- Plan to leave the area (Burlington/Chittenden County) in the next 30 days
- Physical, health, or structural challenge that prevents attendance at outpatient clinic
Other criteria
- Major inclusion criteria include
- STAR referral to outpatient clinic (Addiction Treatment Center and Chittenden Clinic) with prescription for buprenorphine or methadone
- Age ≥18 years
- Provide informed consent
Where in United States
- University of Vermont Medical CenterBurlington, United States
About the trial
What the trial wants to find out
Project Summary The goal of this pilot clinical trial is to assess contingency management (CM) for increasing attendance at outpatient clinics after Medication for Opioid Use Disorder (MOUD) prescription and clinic referral occurred in the hospital Emergency Department (ED).
Read full original descriptionShow less
* The researchers will compare usual care (UC)+CM to UC alone to see if 1) CM works to promote MOUD clinic attendance after discharge from the ED and 2) demonstrate feasibility of providing CM in the ED and outpatient MOUD clinic settings. * Researchers will randomize 30 adults who started MOUD in the ED into two conditions. These conditions consist of (A) UC alone: A referral to an outpatient buprenorphine or methadone provider with reminders from STAR program staff or (B) UC+CM: UC plus financial incentives dependent on MOUD clinic attendance to receive an MOUD prescription.
The primary outcome of interest is the number of participants who receive their first MOUD prescription from the outpatient clinic after discharge from the ED in UC+CM compared to the UC-only condition. A secondary outcome will be the proportion of participants who kept attending outpatient MOUD treatment by the end of the 30-day study period between UC+CM and UC conditions. An exploratory outcome will be biochemically-verified illicit opioid abstinence measured at day 30.
The 2 groups in the trial
- Contingency ManagementTreatment being tested
Participants assigned to this arm will receive incentives when they complete their first outpatient MOUD clinic visit and when they complete subsequent visits to pick up their MOUD prescription for the 30-day study period.
Treatment: Contingency Management and Usual care as prescribed by the ED physicians
- Usual CareExisting treatment, for comparison
All participants will receive standard outpatient care at their clinic.
Treatment: Usual care as prescribed by the ED physicians
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Contingency Management to Improve Medication for Opioid Use Disorder Continuation After Discharge From the Emergency Department
- Record updated
- 20 October 2026